Roberto Iacovelli: The way to increase OS in bladder cancer
Roberto Iacovelli shared a post on X:
”After years and years of inconclusive trials in adjuvant treatment of muscle-invasive bladder cancer (MIBC) and few evidence in adjuvant therapy, Tom Powles and NIAGARA study team show us the way to increase overall survival (OS) in bladder cancer and save lives!”
Source: Roberto Iacovelli/X
Roberto Iacovelli, is a medical oncologist at Fondazione Policlinico Gemelli IRCCS in Rome, Italy. With a focus on genitourinary cancers, his research focuses on metastatic renal cell carcinoma, prostate, and bladder cancer, exploring predictive factors and therapy sequencing. Dr. Iacovelli’s contributions include over 150 publications in peer-reviewed journals and numerous awards for his work, including the ASCO Cancer Foundation Merit Award in 2011.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023